CD73 regulates zoledronate-induced lymphocyte infiltration in triple-negative breast cancer tumors and lung metastases
出版年份 2023 全文链接
标题
CD73 regulates zoledronate-induced lymphocyte infiltration in triple-negative breast cancer tumors and lung metastases
作者
关键词
-
出版物
Frontiers in Immunology
Volume 14, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2023-07-18
DOI
10.3389/fimmu.2023.1179022
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Therapeutic efficacy and mechanism of CD73-TGFβ dual-blockade in a mouse model of triple-negative breast cancer
- (2022) Yun Xing et al. ACTA PHARMACOLOGICA SINICA
- Pamidronate, a promising repositioning drug to treat leishmaniasis, displays antileishmanial and immunomodulatory potential
- (2022) Juliana M. Ribeiro et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- SNAI1-dependent upregulation of CD73 increases extracellular adenosine release to mediate immune suppression in TNBC
- (2022) Meriem Hasmim et al. Frontiers in Immunology
- Correction to: CD73 expression defines immune, molecular, and clinicopathological subgroups of lung adenocarcinoma
- (2021) Pedro Rocha et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor-infiltrating B cells and T cells correlate with postoperative prognosis in triple-negative carcinoma of the breast
- (2021) Hajime Kuroda et al. BMC CANCER
- CD73 facilitates EMT progression and promotes lung metastases in triple-negative breast cancer
- (2021) Nataliia Petruk et al. Scientific Reports
- Neo-CheckRay: radiation therapy and adenosine pathway blockade to increase benefit of immuno-chemotherapy in early stage luminal B breast cancer, a randomized phase II trial
- (2021) Alex De Caluwé et al. BMC CANCER
- Cancer-cell-biomimetic Upconversion nanoparticles combining chemo-photodynamic therapy and CD73 blockade for metastatic triple-negative breast cancer
- (2021) Feiyang Jin et al. JOURNAL OF CONTROLLED RELEASE
- CD73 Promotes Tumor Progression in Patients with Esophageal Squamous Cell Carcinoma
- (2021) Yen-Hao Chen et al. Cancers
- Impact of intratumoural CD73 expression on prognosis and therapeutic response in patients with gastric cancer
- (2021) Xudong He et al. EUROPEAN JOURNAL OF CANCER
- New predictors for immunotherapy responses sharpen our view of the tumour microenvironment
- (2020) Tullia C. Bruno NATURE
- CD73 acts as a prognostic biomarker and promotes progression and immune escape in pancreatic cancer
- (2020) Qiangda Chen et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
- (2020) Nathalie Percie du Sert et al. PLOS BIOLOGY
- Zoledronic acid promotes TLR-4–mediated M1 macrophage polarization in bisphosphonate-related osteonecrosis of the jaw
- (2019) Weiwen Zhu et al. FASEB JOURNAL
- Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways
- (2019) Li Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Zoledronic acid blocks the interaction between breast cancer cells and regulatory T-cells
- (2019) Hsien Liu et al. BMC CANCER
- Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function
- (2019) Selena Vigano et al. Frontiers in Immunology
- A view on drug resistance in cancer
- (2019) Neil Vasan et al. NATURE
- CD73 expression and pathologic response to neoadjuvant chemotherapy in triple negative breast cancer
- (2019) Bruna Cerbelli et al. VIRCHOWS ARCHIV
- Dichotomic effects of clinically used drugs on tumor growth, bone remodeling and pain management
- (2019) David André Barrière et al. Scientific Reports
- Adjuvant Bisphosphonate Therapy in Postmenopausal Breast Cancer
- (2018) Stephanie Strobl et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Adjuvant zoledronic acid reduces fractures in breast cancer patients; an AZURE (BIG 01/04) study
- (2018) C. Wilson et al. EUROPEAN JOURNAL OF CANCER
- Stretching Reduces Tumor Growth in a Mouse Breast Cancer Model
- (2018) L. Berrueta et al. Scientific Reports
- Real-world effectiveness of osteoporosis therapies for fracture reduction in post-menopausal women
- (2018) Akeem A. Yusuf et al. Archives of Osteoporosis
- iDEP: an integrated web application for differential expression and pathway analysis of RNA-Seq data
- (2018) Steven Xijin Ge et al. BMC BIOINFORMATICS
- Proinflammatory CD20+ T cells in the pathogenesis of multiple sclerosis
- (2018) Marina R von Essen et al. BRAIN
- B cell and B cell-related pathways for novel cancer treatments
- (2018) Ryuma Tokunaga et al. CANCER TREATMENT REVIEWS
- B cells inhibit the antitumor immunity against an established murine fibrosarcoma
- (2017) Andrea Maglioco et al. Oncology Letters
- QuPath: Open source software for digital pathology image analysis
- (2017) Peter Bankhead et al. Scientific Reports
- Oral Bisphosphonates and Improved Survival of Breast Cancer
- (2016) Gad Rennert et al. CLINICAL CANCER RESEARCH
- CTLA-4 Limits Anti-CD20–Mediated Tumor Regression
- (2016) Zhenhua Ren et al. CLINICAL CANCER RESEARCH
- Current Challenges in Cancer Treatment
- (2016) Jon Zugazagoitia et al. CLINICAL THERAPEUTICS
- Features of Human CD3+CD20+T Cells
- (2016) Elisabeth Schuh et al. JOURNAL OF IMMUNOLOGY
- CAPG and GIPC1: Breast Cancer Biomarkers for Bone Metastasis Development and Treatment
- (2016) Jules A. Westbrook et al. JNCI-Journal of the National Cancer Institute
- Zoledronate and Molecular Iodine Cause Synergistic Cell Death in Triple Negative Breast Cancer through Endoplasmic Reticulum Stress
- (2016) Ranu Tripathi et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Toll-like receptor 9 expression is associated with breast cancer sensitivity to the growth inhibitory effects of bisphosphonates in vitro and in vivo
- (2016) Jouko Sandholm et al. Oncotarget
- CAPG and GIPC1: Breast Cancer Biomarkers for Bone Metastasis Development and Treatment
- (2016) Jules A. Westbrook et al. JNCI-Journal of the National Cancer Institute
- Clinical significance of tumor-infiltrating lymphocytes in breast cancer
- (2016) Sasha E. Stanton et al. Journal for ImmunoTherapy of Cancer
- Altered macrophagic THP-1 cell phagocytosis and migration in bisphosphonate-related osteonecrosis of the jaw (BRONJ)
- (2015) Sebastian Hoefert et al. Clinical Oral Investigations
- StringTie enables improved reconstruction of a transcriptome from RNA-seq reads
- (2015) Mihaela Pertea et al. NATURE BIOTECHNOLOGY
- HISAT: a fast spliced aligner with low memory requirements
- (2015) Daehwan Kim et al. NATURE METHODS
- Zoledronate can promote apoptosis and inhibit the proliferation of colorectal cancer cells
- (2015) Xiang Gao et al. TUMOR BIOLOGY
- Margin-Infiltrating CD20+ B Cells Display an Atypical Memory Phenotype and Correlate with Favorable Prognosis in Hepatocellular Carcinoma
- (2013) J.-Y. Shi et al. CLINICAL CANCER RESEARCH
- Bisphosphonates Target B Cells to Enhance Humoral Immune Responses
- (2013) Elena Tonti et al. Cell Reports
- Bisphosphonates in the Adjuvant Treatment of Breast Cancer
- (2012) M.C. Winter et al. CLINICAL ONCOLOGY
- Inhibition of CD73 Improves B Cell-Mediated Anti-Tumor Immunity in a Mouse Model of Melanoma
- (2012) G. Forte et al. JOURNAL OF IMMUNOLOGY
- Estrogen receptor-α and sex steroid hormones regulate Toll-like receptor-9 expression and invasive function in human breast cancer cells
- (2011) Jouko Sandholm et al. BREAST CANCER RESEARCH AND TREATMENT
- Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis
- (2010) J. Stagg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
- (2009) M. D. Robinson et al. BIOINFORMATICS
- Zoledronic acid induces apoptosis and changes the TRAIL/OPG ratio in breast cancer cells
- (2009) Tilman D. Rachner et al. CANCER LETTERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now